{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Danbury",
      "state": "CT",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78172",
      "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "address_1": "39 Briar Ridge Rd.",
      "address_2": "",
      "postal_code": "06810",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "CO, OH",
      "recall_number": "D-0007-2018",
      "product_description": "Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01",
      "product_quantity": "128 bottles",
      "reason_for_recall": "Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.",
      "recall_initiation_date": "20170922",
      "center_classification_date": "20171006",
      "termination_date": "20180418",
      "report_date": "20171018",
      "code_info": "Lot 754037",
      "more_code_info": ""
    }
  ]
}